NM_000069.3(CACNA1S):c.3526-197A>G AND not provided
- Germline classification:
- Likely benign (1 submission)
- Last evaluated:
- Jun 18, 2018
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000837968.1
Allele description [Variation Report for NM_000069.3(CACNA1S):c.3526-197A>G]
NM_000069.3(CACNA1S):c.3526-197A>G
Condition(s)
- Synonyms:
- none provided
- Identifiers:
- MedGen: C3661900
-
Critical Appraisal - Clinical and Economic Review Report: Infliximab SC (Remsima...
Critical Appraisal - Clinical and Economic Review Report: Infliximab SC (Remsima)
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Dec 24, 2023